About Phlexglobal
Phlexglobal is a Healthcare company based in Amersham (United Kingdom) founded in 1997, and was acquired by Vitruvian Partners in December 2016. Clinical trial documents are managed via eTMF systems and services. Phlexglobal has completed 2 acquisitions, including Cunesoft and Net Solutions Europe. Phlexglobal offers products and services including PhlexTMF V21, TMF Quality Review, TMF Heatmaps, and Migrations and Imports. Its focus areas include HealthTech, Life Sciences Tech, GRC Solutions and Medical Writing. Its legal entity is PHLEXGLOBAL LIMITED.
Company details
Phlexglobal was founded in 1997 in Amersham, United Kingdom, and operates in the life sciences sector. Electronic Trial Master File (eTMF) systems, including the PhlexEview platform, are provided alongside quality services and specialist resources. Technical expertise, clinical trial knowledge, and regulatory compliance are applied across the document lifecycle, encompassing creation, approval, query management, quality control, system integration, business intelligence, and electronic archiving.
- Headquarters Amersham, United Kingdom
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website phlexglobal.com
- Social LinkedIn X Facebook YouTube
- Acquired by Vitruvian Partners (Dec 2016)
- Legal Name Phlexglobal Limited
- Date of Incorporation 14 Apr, 1998
- Jurisdiction CHESHAM, ENGLAND
Products & Services of Phlexglobal
Phlexglobal offers a comprehensive portfolio of products and services, including PhlexTMF V21, TMF Quality Review, TMF Heatmaps, and Migrations and Imports.
Software for managing trial master files in clinical trials.
Assessment of TMF quality and completeness for compliance.
Identifies TMF problem areas for risk-based remediation.
Ensures GCP standards for essential document handling.
Apps and channels of Phlexglobal
its YouTube channel Phlexglobal - a Cencora PharmaLex company has 336 subscribers and 30 videos.
Videos from Phlexglobal
The most watched videos on Phlexglobal's YouTube channel, Phlexglobal - a Cencora PharmaLex company (336 subscribers). Click a video to play it here.
Funding Insights of Phlexglobal
- Total Rounds 2
- Investors Count 3
All 2 funding rounds of Phlexglobal with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Apr 2016 | Unspecified | – | OCCIDENT – The Science Investor. | ||
| Oct 2014 | Unspecified | – | HTGF, Bayern Kapital | – |
6 investors in total: 6 institutional.
Investors in Phlexglobal
Phlexglobal has secured backing from 6 investors, including venture fund investors. Prominent investors backing the company include Inflexion, Bridgepoint Capital and OCCIDENT.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Venture capital investments are provided to deep-tech startups. | occident.group | Munich, Germany | ||
Early-stage investments are made in high-tech startups by HTGF. | htgf.de | Bonn, Germany | ||
High-tech industries are targeted for investments by Bayern Kapital. | bayernkapital.de | Landshut, Germany | ||
Growth equity investments are directed toward expanding startups across sectors. | vitruvianpartners.com | London, United Kingdom | ||
Inflexion is engaged in mid-market private equity investments across Europe. | 1999 | inflexion.com | London, United Kingdom | |
Middle-market businesses up to €1 billion are acquired pan-Europe. | 1984 | bridgepoint.eu | Frankfurt, Germany |
Investor details for Phlexglobal
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Phlexglobal
Phlexglobal has strategically engaged in corporate development activities, having acquired 2 companies. Notable acquisitions include Cunesoft and Net Solutions Europe.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Cloud-based regulatory software solutions | cunesoft.com | Munich, Germany | 2013 | Jan 2020 | •••• | |
Managed hosting and application development services are offered. | nse.co.uk | Amersham, United Kingdom | 1996 | Jan 2016 | •••• |
Complete acquisition details for Phlexglobal
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Phlexglobal
8 dated milestones of Phlexglobal across 23 years, from founding to its latest funding, stage changes and deals.
- Founded Phlexglobal is founded.
- Exit Acquired by Inflexion.
- Exit Acquired by Bridgepoint Capital.
- Funding First funding round.
- Acquisition Acquires Net Solutions Europe.
- Funding Latest funding round, Unspecified,.
- Exit Acquired by Vitruvian Partners.
- Acquisition Acquires Cunesoft.
Web traffic of Phlexglobal
The website of Phlexglobal (phlexglobal.com) receives about 2.7K visits a month.
- Monthly visits2.7K
▲ 42.2% vs previous month
Websites whose visitors overlap most with Phlexglobal. Affinity shows how closely the audiences match.
| Website | Domain | Audience affinity | Monthly visits | Global rank | Profile |
|---|---|---|---|---|---|
| hendersonscott.com | 97% | 17.6K | View details |
Top companies in Life Sciences Platforms & Tools
3 companies that operate in the same segment as Phlexglobal (Life Sciences Platforms & Tools) in United Kingdom, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.34 B | USD 301.49 M | 1,372 | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | |||
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Related news about Phlexglobal
Complete news archive for Phlexglobal
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Phlexglobal
Phlexglobal was founded in 1997 and raised its 1st funding round 17 years after it was founded.
Phlexglobal is headquartered in Amersham, United Kingdom. It is registered at Amersham, England, United Kingdom.
Phlexglobal was founded in 1997 in Amersham, United Kingdom, and operates in the life sciences sector. Electronic Trial Master File (eTMF) systems, including the PhlexEview platform, are provided alongside quality services and specialist resources. Technical expertise, clinical trial knowledge, and regulatory compliance are applied across the document lifecycle, encompassing creation, approval, query management, quality control, system integration, business intelligence, and electronic archiving.
Phlexglobal offers PhlexTMF V21, TMF Quality Review, TMF Heatmaps, and Migrations and Imports.
Phlexglobal has made 2 acquisitions, including Cunesoft, and Net Solutions Europe.
Phlexglobal has 6 investors. Key investors include Inflexion, Bridgepoint Capital, OCCIDENT, High-Tech Gründerfonds, and Bayern Kapital.
Phlexglobal operates through Phlexglobal Limited.
Yes. Phlexglobal was acquired by Vitruvian Partners in December 2016.